TITLE

Abnormal Na-li Countertransport Kinetics in Type 1 Diabetic Patients with Nephropathy and in Their Parents

AUTHOR(S)
Zerbini, Gianpaolo; Maestroni, Anna; Maestroni, Silvia; Gabellini, Daniela; Luzi, Livio
PUB. DATE
June 2007
SOURCE
Diabetes;Jun2007 Supplement 1, Vol. 56, pA91
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
An inherited predisposition to essential hypertension is presently considered the most important cause of susceptibility to nephropathy in diabetic patients. This hypothesis is confirmed by the evidence that diabetic nephropathy is characterized by an increased activity of erythrocyte Na-Li counter-transport (SLC), the most consistent intermediate phenotype of essential hypertension. Although family studies and genetic epidemiology have suggested that variability of SLC measured at 150 mM external Na (standard assay) is under genetic control, it is unknown whether family members share similar SLC kinetic parameters. To clarify this issue we have therefore evaluated Vmax and Km for external Na of SLC in 21 type 1 diabetic patients with increased albumin excretion rate, in 25 normoalbuminuric patients matched for age, gender and duration of diabetes, and in their parents. As a result, SLC activity (standard assay) was confirmed to be increased in patients with diabetic nephropathy (547.9±51 µmol⋅lcell-1⋅h-1 mean±SEM) when compared to normoalbuminuric patients (381.0±30, p=0.02). Both Vmax (668.3±69 vs 428.4±37 µmol⋅1cell-1⋅h-1, p=0.004) and Km for external Na (61.1±5 vs 34.9±3 mM Na, p=0.0001) were also increased in patients with nephropathy. In parents of patients with nephropathy SLC activity (standard assay) was higher, though not significantly, that in parents of normoalbuminurics (423.8±127 vs 354.3±29 µmol⋅1cell-1⋅h-1, p=0.09). Both Vmax (518.7±35 vs 386.7±18 µmol⋅1cell-1⋅h-1, p=0.0007) and Km for external Na (57.5±4 vs 34.2±4 mM Na, p=0.0001) were instead significantly increased in parents of patients with nephropathy Finally, Vmax and Km of patients were respectively correlated to the mean of the Vmaxs (r2=0.42, p=0.0001) and Kms (r2=0.46, p=0.0001) of parents. In conclusion, this results demonstrate that a dysfunction of both Vmax and Km for external Na of SLC characterizes type 1 diabetic patients with nephropathy and their parents. This finding suggests that the SLC carrier is possibly affected by a major structural damage in nephropatic patients and that this dysfunction is probably extended also to relatives.
ACCESSION #
25820664

 

Related Articles

  • Red cell Na+/Li+ countertransport in non-insulin-dependent diabetics with diabetic nephropathy. Gall, Mari-Anne; Rossing, Peter; Jensen, Jan S.; Funder, Jørgen; Parving, Hans-Henrik // Kidney International;Jan1991, Vol. 39 Issue 1, p135 

    Genetic predisposition to essential hypertension, as indicated by increased maximal velocity of Na+/Li+ countertransport in red cells, has been suggested as a marker for the risk of developing diabetic nephropathy. To evaluate the validity of this concept in non-insulin-dependent diabetics, we...

  • NEPHROPATHY. Watkins, Peter J. // British Medical Journal (Clinical Research Edition);8/28/1982, Vol. 285 Issue 6342, p627 

    Presents a clinical course on nephropathy. Hallmark of diabetic nephropathy; Onset of nephropathy; Management of diabetes during transplantation and dialysis.

  • Is endothelial dysfunction more deleterious than podocyte injury in diabetic nephropathy? Nakagawa, Takahiko // Kidney International;Jun2013, Vol. 83 Issue 6, p1202 

    A letter to the editor is presented about the danger associated with endothelial dysfunction in individuals with diabetic glomerular disease.

  • In this Issue.  // Kidney International;Jul2009, Vol. 76 Issue 1, p1 

    The article discusses various reports published within the issue, including the metabolic anomalies in patients with advanced chronic kidney disease (CKD), the role of Stat3 in the development of diabetic nephropathy in mice and outcome assessment of automated cycling machines in patients with...

  • Medical biochemistry.  // Clinical & Investigative Medicine;Aug97 Supplement, Vol. 20, pS47 

    Presents an abstract of the research manuscript `Oxidative stress in diabetic kidney: A time course study,' by R. Kakkar et al. Diabetic complications.

  • Genetics and Diabetic Renal Disease. Mogensen, Carl Erik // Diabetes Care;May2003, Vol. 26 Issue 5, p1631 

    States that diabetic renal disease is an important and common complication in both type 1 and type 2 diabetic patients. Cumulative incidence of proteinuria; Risk factors for development of nephropathy; Rate of progression according to genotype; Studies on genetics and diabetic nephropathy;...

  • Sodium-lithium countertransport activity in red cells of patients with insulin dependent diabetes and nephropathy and their parents. Walker, James D.; Tariq, Taimur; Viberti, Giancarlo // BMJ: British Medical Journal (International Edition);9/29/90, Vol. 301 Issue 6753, p635 

    Examines the presence of the familial and genetic aspects of sodium-lithium countertransport activity in red cells in patients with diabetic nephropathy in Europe. Rise in sodium-lithium countertransport activity in patients with proteinuria; Increase in mean countertransport activity in...

  • Affecting the decline of renal function in diabetes mellitus. Steffes, Michael W. // Kidney International;Jul2001, Vol. 60 Issue 1, p378 

    Editorial. Introduces an article on the signs and symptoms of advanced clinical diabetic nephropathy, published on the June 25, 2001 issue of the `Kidney International.' Stages of diabetic nephropathy; Effectiveness of antihypertensive medications; Implications for clinicians.

  • Up-regulation of monocyte chemoattractant protein-1 in tubulointerstital lesions of human diabetic nephropathy. Wada, Takashi; Furuichi, Kengo; Sakai, Norihiko; Iwata, Yasunori; Yoshimoto, Keiichi; Shimizu, Miho; Takeda, Shin-Ichi; Takasawa, Kazuya; Yoshimura, Mitsuhiro; Kida, Hiroshi; Kobayashi, Ken-Ichi; Mukaida, Naofumi; Naito, Takero; Matsushima, Kouji; Yokoyama, Hitoshi // Kidney International;Oct2000, Vol. 58 Issue 4, p1492 

    Examines the role of monocyte chemoattractant protein-1 (MCP-1) in progressive glomerular and interstitial damage in inflammatory renal diseases. Expression of MCP-1 in diabetic nephropathy; Elevation of urinary MCP-1 levels in patients with diabetic nephropathy; Formation of tubulointerstitial...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics